|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01833 PA GOODDOCTOR
Nominal 
6.580 -0.550 (-7.714%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 2,483,833 | -0.734% | 2,502,193 | 2,093,449 | 2,222,177 | 2,830,955 |
| Cost of Sales | (1,527,163) | -8.140% | (1,662,484) | (1,419,651) | (1,506,815) | (2,079,317) |
| Gross Profit | 956,670 | 13.929% | 839,709 | 673,798 | 715,362 | 751,638 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (1,011) | -96.651% | (30,190) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (10,044) | -- | 1,359 | (268) | (2,415) | (35,131) | |
| Profit / (Loss) before Taxation | 250,653 | 83.952% | 136,260 | 60,652 | (244,263) | (460,403) | |
| Taxation | (30,880) | 2184.024% | (1,352) | (23) | (604) | (3,538) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (441) | -40.726% | (744) | (3,981) | 249 | 1,486 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 219,332 | 63.481% | 134,164 | 56,648 | (244,618) | (462,455) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (44,612) | -25.688% | (60,033) | (102,436) | (127,319) | (140,043) |
| Depreciation & Amortisation | 37,788 | 0.543% | 37,584 | 52,529 | 85,126 | 104,218 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 10.000 | 42.857% | 7.000 | 5.000 | -23.000 | -43.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.665 | -- | 4.490 | 11.958 | 11.933 | 12.098 |
| Remarks: | Real time quote last updated: 20/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 219,332 |
| %Change | 63.481% |
| EPS / (LPS) | RMB 0.100 |
| NBV Per Share (¥) | RMB 4.665 |